Akiko Mori is a highly experienced professional in the pharmaceutical and medical research fields, currently serving as Medical Lead for Alzheimer's disease at Biogen Japan since July 2020. Notable prior positions include Group Manager at Mitsubishi Tanabe Pharma Corporation, where Akiko managed a CNS research group focused on Alzheimer's drug development, and Principal Research Scientist at Mitsubishi Pharma Corporation, leading a cross-functional CNS R&D program. Akiko has also served as a Medical Communications Manager at Amgen Astellas BioPharma and held roles at Eli Lilly Japan, where strategic medical education initiatives were implemented. Early research experience includes a post-doctoral fellowship at Stanford University focusing on neural stem cell research and significant contributions to understanding circadian rhythm at Tokyo Mitsubishi Pharmaceutical Company.
This person is not in the org chart
This person is not in any teams
This person is not in any offices